What You Need to Know
- The law's "cost-sharing" limit now helps the clients using their Medicare Part B benefits to pay for insulin.
The new federal cost-sharing limits for Medicare enrollees who use insulin could now help more of your clients.
The Inflation Reduction Act of 2022 imposed a $35-per-month cap on how much clients with Medicare Part D prescription drug coverage pay for their insulin starting Jan. 1.
Some clients with diabetes may get insulin through pumps purchased through Medicare Advantage plans or through the “Original Medicare” Part B outpatient hospital services and physician services plan. For them, the $35 cap took effect on July 1.
What It Means
Some clients with diabetes may now spend less on insulin.
Medicare Supplement Insurance
Some clients might use Original Medicare together with Medicare supplement insurance.